Market Tracker

04/23 6:05pm ET

Theravance Inc (NASDAQ:THRX)

27.07
Data as of Apr 23
 -0.48 / -1.74%
Today’s Change
26.04
Today|||52-Week Range
42.96
-24.07%
Year-to-Date

Today’s Trading

Previous close27.55
Today’s open28.09
Day’s range26.76 - 28.09
Volume1,030,210
Average volume (3 months)998,333
Market cap$3.1B
Dividend yield--
Data as of 3:59pm ET, 04/23/2014

Growth & Valuation

Earnings growth (last year)-735.00%
Earnings growth (this year)+27.20%
Earnings growth (next 5 years)+3.00%
Revenue growth (last year)-96.50%
P/E ratioNM
Price/Sales767.43
Price/Book10.44

Competitors

 Today’s
change
Today’s
% change
MYGNMyriad Genetics Inc+0.28+0.71%
NPSPNPS Pharmaceuticals ...-0.70-2.63%
MNKDMannkind Corp-0.09-1.40%
MNKMallinckrodt Plc+1.03+1.63%
Data as of 4:05pm ET, 04/23/2014

Financials

Next reporting dateMay 7, 2014
EPS forecast (this quarter)-$0.53
Annual revenue (last year)$4.8M
Annual profit (last year)-$170.7M
Net profit margin-3,587.66%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Rick E. Winningham
Senior Vice President-
Operations
Frank C. Pasqualone
Corporate headquarters
South San Francisco, California

Forecasts